feed,title,long_url,short_url
Benzinga,Sanofi and GSK initiate Phase 1/2 clinical trial of COVID-19 adjuvanted recombinant protein-based vaccine candidate,https://www.benzinga.com/pressreleases/20/09/g17363012/sanofi-and-gsk-initiate-phase-12-clinical-trial-of-covid-19-adjuvanted-recombinant-protein-based-v,https://j.mp/3i0yJdO
Benzinga,Kiadis announces investor events for September 2020,https://www.benzinga.com/pressreleases/20/09/g17363011/kiadis-announces-investor-events-for-september-2020,https://j.mp/3hPw3PU
